successful ODT for is 463.5HU (67.7% Sensitivity, 68.9% Specificity, AUC 0.7, P¼0.007).
INTRODUCTION AND OBJECTIVES: Improved methods of stone prevention are needed to combat rising rates of nephrolithiasis. Achieving adequate fluid intake is an effective strategy; yet, patient compliance with recommendations is generally poor. Mobile health applications and smart technology show promise as tools to improve compliance with medically indicated dietary treatments; however, have yet to be applied specifically towards stone formers with low urinary volume. Recently, a smart water bottle (HidrateSpark TM , Boulder, CO) was introduced as a noninvasive fluid intake monitoring system. This device could conceivably help patients who form stones from low urine volume achieve sustainable improvements in hydration, but has yet to be validated as a useful instrument. We sought to verify its accuracy prior to considering its potential as a medical aide.
METHODS: HidrateSpark ( Figure 1 ) uses capacitive touch sensing via a sensor extending from the lid to base, which calculates volume measurements by detecting changes in water level. Data from the bottle is sent wirelessly to users 0 smartphones through an application. A pilot study was conducted to assess accuracy of measured fluid intake over 24 hour periods when used in a real life setting. Subjects were provided smart bottles to sync with their smartphone and given short tutorials on their use. Accuracy was determined by comparing 24 hour measurements recorded through the smart bottle to hand measurements from the corresponding 24 hour period.
RESULTS: Eight subjects performed 62 24-hour measurements (range 4-14). Mean 24 hour hand measurement was 57.2 ozs (21-96). Corresponding mean 24 hour smart bottle measurement underestimated true fluid intake by a mean of 0.5 ozs (95% CI -1.9, 0.9). The percent difference between hand and smart bottle measurements was 0.0% (95% CI -3%, 3%). The intraclass correlation coefficient (ICC) was calculated to assess consistency between hand measures and bottle measures. The ICC (95% CI) was found to be 0.97 (0.95,0.98) indicating and extremely high consistency between measures.
CONCLUSIONS: 4 hour fluid intake measurements taken through a novel fluid monitoring system (HidrateSpark) are accurate to within 3%. Such technology may be useful as a behavioral aide and/or research tool particularly among recurrent stone formers with low urinary volume.
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A NOVEL USE OF STRUCTURED WATER FOR THE PREVENTION OF RECURRENT STONES IN IDIOPATHIC HYPERCALCIURIA.
Ali Sami*, Suleimany, Iraq INTRODUCTION AND OBJECTIVES: The majority of stones (85%) contain primarily calcium oxalate. Most renal stones are idiopathic calcium stones, and the most common predisposing factor in these patients is hypercalciuria. Structured water is a new type of water that has been prepared using different types of energy fields and modulators to produce this structured water that has new and different characteristics from the ordinary water. In this study, we compared the efficacy of the structured water (Magnalifeâ) with hydrochlorothiazide and with ordinary bottled water in the prevention of recurrent renal stones in patients with idiopathic hypercalciuria.
METHODS: We conducted a three-year randomized trial comparing the effect of structured water with the effect of hydrochlorothiazide and ordinary bottled water in 300 patients with recurrent calcium oxalate stones and hypercalciuria. 100 men used structured water (Magnalifeâ). The other 100 men used 50 mg hydrochlorothiazide, and 100 men used ordinary bottled water. Urine analysis with renal ultrasonography and radiology were done at baseline and at yearly intervals and any time of recurrence and at the end of the 3 years (36th month). All patients were informed and signed a written informed consent form.
RESULTS: Of the 300 men included in this study, 95 had recurrent stones, 15 men (15%) in the group of structured water ,31 men (31%) in the hydrochlorothiazide group, and 49 men (49%) in the group of ordinary bottled water. The difference in the recurrence rate between the structured water group and the hydrochlorothiazide group is significant (P¼0.007) Also the difference between the difference between the structured water group and the ordinary water group is significant (p<0.001), furthermore the hydrochlorothiazide group and the ordinary bottled water group recurrence rate is significantly different (P¼0.009).
CONCLUSIONS: Structured water is a safe, effective, and affordable new way to prevent recurrent urinary stones without the need for medications that are expensive and have many side effects. Furthermore, it is more potent than some preventive measures and drugs as a prophylactic way against recurrent urinary stones. It is far more effective than ordinary bottled water in preventing recurrent stones. Further studies are recommended to explore its role in other fields of urology. Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1211
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